Home NDC 24338-153 XIFYRM
Product NDC 24338-153
11-digit product format 243380153
Labeler code 24338
Product ID 24338-153_bf2b198c-0726-488a-b911-4fe394e4b56e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name meloxicam
Dosage form INJECTION
Route INTRAVENOUS
Labeler Azurity Pharmaceuticals, Inc.
Application NDA218395
Marketing category NDA
Marketing start 2025-06-05
Substance MELOXICAM
Active strength 30 mg/mL
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218395-001 XIFYRM MELOXICAM 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-06-05
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218395-001 12263176 2041-07-31 Drug product 2025-06-06
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218395-001 XIFYRM 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-06-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218395-001 XIFYRM 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-06-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218395-001 XIFYRM 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-06-05 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218395-001 XIFYRM 30MG/ML (30MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2025-06-05 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218395-001 12263176 2041-07-31 Drug product 2025-06-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218395-001 12263176 2041-07-31 Drug product 2025-06-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218395-001 12263176 2041-07-31 Drug product 2025-06-06 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218395-001 12263176 2041-07-31 Drug product 2025-06-06 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base XIFYRM
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MELOXICAM 30 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination VG2QF83CGL Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2281106 Internal RxNorm lookup 2717320 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 24338-153-01 XIFYRM 1 mL in 1 VIAL, SINGLE-DOSE INJECTION 1 1 24338-153-02 XIFYRM 10 in 1 CARTON INJECTION 10 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join XIFYRM MELOXICAM Azurity Pharmaceuticals, Inc. bf2b198c-0726-488a-b911-4fe394e4b56e 2025-06-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 218395 application number: NDA218395 ndc (product): 24338-153
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 24338-153-01 24338015301 1 mL in 1 VIAL, SINGLE-DOSE 1 ml Historical 24338-153-02 24338015302 10 VIAL, SINGLE-DOSE in 1 CARTON (24338-153-02) / 1 mL in 1 VIAL, SINGLE-DOSE (24338-153-01) 2025-06-05 No No Current